Your session is about to expire
← Back to Search
tDCS for OCD in Children
This trial will test whether tDCS can help lessen OCD symptoms in children.
- Pediatric Mental Health Disorder
- Obsessive-Compulsive Disorder
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Side effects dataFrom 2021 Phase 2 & 3 trial • 160 Patients • NCT02483468
Awards & Highlights
Find a Location
Who is running the clinical trial?
- You cannot participate if you have a history of epilepsy or have metal implants, brain or vagus nerve stimulators, VP shunt or pacemakers in your head or neck.Your body mass index (BMI) is too low.You have been diagnosed with certain mental health conditions like conduct disorder, autism, bipolar disorder, ADHD, Tourette's syndrome, schizophrenia, or schizoaffective disorders based on DSM-V criteria.Young people who have symptoms of hoarding because their condition may be different from other types of OCD.You are addicted to drugs or alcohol (excluding tobacco).You started taking an antidepressant within 12 weeks or an antipsychotic within 6 weeks before joining the study. You cannot start any new alternative medications, special diets, or therapies within 6 weeks of joining the study.If you are currently receiving therapy for your OCD, you cannot participate in the study unless it is for maintenance purposes only. However, if you have been receiving therapy for other psychological issues for at least 8 weeks, you may still be eligible to enroll.You have had suicidal thoughts or behaviors within the past 6 months and need to receive proper mental health treatment.
- Group 1: Inhibitory Control/ Fear Extinction
- Group 2: Inhibitory Control/ Goal-Orientated vs Habit-Based Behavior
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What characteristics make a patient eligible for this clinical investigation?
"For this medical investigation, 36 outpatients aged 10 to 17 with a WASI-II IQ of at least 85 and who are suffering from obsessive compulsive disorder will be accepted. In cases where intellectual disability is suspected, the PI may administer an additional WASI-II test in order to reduce participant strain."
Is recruitment for this research endeavor still open?
"Affirmative. The information hosted on clinicaltrials.gov reveals that this study is recruiting. It was initially posted on January 25th 2021 and the most recent update occurred on July 21st 2022. This trial requires 36 participants from a single medical center to be enrolled in order for it to move ahead with research plans."
Are individuals aged 55 and above eligible for enrollment in this trial?
"This research project is open to participants whose age ranges from 10 years old and under 17."
How many participants are currently enlisted in this clinical trial?
"Affirmative, clinicaltrials.gov confirms that recruitment for this experiment is in progress. This trial was published on January 25th 2021 and most recently updated July 21st 2022 with the goal of recruiting 36 participants from one medical centre."
Share this study with friends